Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

Finnerty, James; Ponnuswamy, Aravind; Dutta, Prosjenjit; Abdelaziz, Ammar; G Kamil, H

doi:10.1186/s12890-021-01783-1

Public

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

Published in BMC Pulmonary Medicine • Dec 1, 2021

Authors:

James Finnerty

Aravind Ponnuswamy

Prosjenjit Dutta

Abstract

BACKGROUND: Research questions To compare the efficacy of nintedanib and pirfenidone in the treatment of progressive pulmonary fibrosis; and to compare the efficacy of anti-fibrotic therapy (grouping nintedanib and pirfenidone together) in patients with IPF versus patients with progressive lung fibr...

Subject

Nintedanib

Pirfenidone

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!